Consensus LeMaitre Vascular, Inc.

Stocks

LMAT

US5255582018

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-02 EDT			5-day change	1st Jan Change
102.88 ^USD	+4.19%		+7.55%	+26.86%

05-12	Lemaitre Vascular Insider Sold Shares Worth $5,032,413, According to a Recent SEC Filing	MT
05-11	Lemaitre Vascular Insider Sold Shares Worth $313,287, According to a Recent SEC Filing	MT

Evolution of the Average Target: LeMaitre Vascular, Inc.

Evolution of the Target Price: LeMaitre Vascular, Inc.

Changes in Analyst Recommendations: LeMaitre Vascular, Inc.

2984.45UJpJvfbK-tpaPeSLBzneh-1VGAPa11e_VKfUFw790.l8Fx4NWaBObB1vGEPuEa9rAKlmfDDMotVsV6Diop2Ieg0DDX77o_x_7UwA~85cd9a308b3245b6dffa962bd99cb136

Analysts' recommendations: LeMaitre Vascular, Inc.

05-06	Barrington Adjusts Price Target on LeMaitre Vascular to $120 From $105, Maintains Outperform Rating	MT
02-26	LeMaitre Vascular Shares Rise After Barrington Price Target Boost, Q4 Results	MT
02-26	Barrington Adjusts Price Target on LeMaitre Vascular to $105 From $95, Maintains Outperform Rating	MT
25-08-05	Medical device firm LeMaitre Q2 sales beat expectations	RE
25-02-28	Oppenheimer Downgrades LeMaitre Vascular to Market Perform From Overweight, Price Target is $45	MT
25-02-13	Wells Fargo Initiates LeMaitre Vascular at Equalweight With $95 Price Target	MT
24-10-15	Cantor Fitzgerald Initiates LeMaitre Vascular at Neutral With $96 Price Target	MT
24-05-31	Roth MKM Upgrades LeMaitre Vascular to Buy Rating With $100 Price Target	MT
24-05-03	Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating	MT
24-04-26	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59	MT
24-02-28	Barrington Raises Price Target on LeMaitre Vascular to $69 From $66, Keeps Outperform Rating	MT
23-10-23	JMP Securities Initiates LeMaitre Vascular With Market Outperform Rating, Price Target is $60	MT
23-09-06	Oppenheimer Initiates Coverage on LeMaitre Vascular With Outperform Rating, $70 Price Target	MT
23-08-03	Jefferies Downgrades LeMaitre Vascular to Hold From Buy, Adjusts Price Target to $67 From $63	MT
23-08-02	Barrington Raises Price Target on LeMaitre Vascular to $66 From $62, Maintains Outperform Rating	MT
23-05-03	Stifel Raises LeMaitre Vascular's Price Target to $60 From $48, Hold Rating Kept	MT
23-05-03	Jefferies Raises LeMaitre Vascular's Price Target to $63 From $57, Maintains Buy Rating	MT
23-05-03	Roth MKM Raises LeMaitre Vascular's Price Target to $54 From $48, Neutral Rating Kept	MT
23-05-03	Barrington Research Upgrades LeMaitre Vascular to Outperform From Market Perform	MT
22-10-28	Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform	MT
22-04-29	Barrington Lowers LeMaitre Vascular's Price Target to $50 From $54, Maintains Outperform Rating	MT
22-02-25	Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating	MT
21-10-29	Barrington Adjusts Price Target on LeMaitre Vascular to $62 From $64, Maintains Outperform Rating	MT
21-09-16	LEMAITRE VASCULAR : Jefferies Initiates LeMaitre Vascular at Buy Rating With $70 Price Target	MT
21-08-03	LEMAITRE VASCULAR : Roth Capital Adjusts LeMaitre Vascular's Price Target to $58 from $55, Keeps Neutral Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	LEMAITRE VASCULAR, INC.					+15.43%
	THERMO FISHER SCIENTIFIC, INC.					+13.91%
	INTUITIVE SURGICAL, INC.					+32.64%
	DANAHER CORPORATION					+22.44%
	BOSTON SCIENTIFIC CORPORATION					+66.15%
	EDWARDS LIFESCIENCES CORPORATION					+3.11%
	SIEMENS HEALTHINEERS AG					+37.33%
	WATERS CORPORATION					+6.22%
	AGILENT TECHNOLOGIES, INC.					+22.68%
	RESMED, INC.					+24.31%
	Average					+24.42%
	Weighted average by Cap.					+24.91%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

102.88USD

Average target price

118.75USD

Spread / Average Target

+15.43%

High Price Target

135.00USD

Spread / Highest target

+31.22%

Low Price Target

102.00USD

Spread / Lowest Target

-0.86%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Barrington Research
Oppenheimer
Wells Fargo Securities
Cantor Fitzgerald
Roth MKM
Stifel Nicolaus
JMP Securities
Jefferies & Co.
Roth Capital Partners
KeyBanc Capital Markets